Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-22

Clinical Trial Update: Efficacy Study Between Two Different Dosages of an Antiparasitic in Patients With Crusted Scabies [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing two dosages of an antiparasitic for crusted (Norwegian) scabies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVERMECTIN (Ivermectin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Gale, Severe Forms of Scabies | Phase 3 | Status: COMPLETED